Categories AlphaGraphs, Earnings, Technology

Earnings: Here’s everything you need to know about Microsoft’s Q4 results

Microsoft Corp. (NASDAQ: MSFT) on Tuesday reported financial results for the fourth quarter of 2023. The tech giant’s cloud business continued to expand during the period.

Microsoft Q4 2023 earnings infographic

The company reported fourth-quarter revenues of $56.2 billion, compared to $51.9 billion in the same period of 2022. Net profit came in at $20.08 billion or $2.69 per share in the June quarter, vs. $16.74 billion or $2.23 per share in the comparable period of last year.

“We remain focused on leading the new AI platform shift, helping customers use the Microsoft Cloud to get the most value out of their digital spend, and driving operating leverage,” said Microsoft’s CEO Satya Nadella.

Prior Performance

  • Microsoft Q2 2023 earnings infographic
  • Microsoft Q1 2023 earnings infographic
  • Microsoft Q4 2022 earnings infographic

_________________________________________________________________________________________________________________

Stocks you may like:

Apple (AAPL) Stock

Microsoft (MSFT) Stock

Alphabet (GOOGL) Stock

International Business Machines Corp. (IBM) Stock

_________________________________________________________________________________________________________________

Most Popular

Nike (NKE) looks set to beat hurdles and build a brighter future

Nike, Inc. (NYSE: NKE) has long been ruling the sportswear market but the company had its share of problems when headwinds like the pandemic and economic slowdown hit the business

Electronic Arts (EA): A few points to keep in mind if you have an eye on this gaming company

Shares of Electronic Arts Inc. (NASDAQ: EA) stayed green on Friday. The stock has dropped 7% over the past three months. The video game industry has been facing challenges as

Petros Pharma is focused on establishing mechanisms for Rx-to-OTC switch: CCO Fady Boctor

Petros Pharmaceuticals, Inc. (NASDAQ: PTPI) is a pharma company focused on identifying, developing, and commercializing therapeutics for men's health issues. It operates mainly through the business segments of Prescription Medications

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top